颈动脉内膜切除术与冠状动脉旁路移植术同期与分期手术的围手术期及长期结局
基于VQI-VISION-Medicare关联数据,比较2011至2018年1058例颈动脉内膜切除术(CEA)联合冠状动脉旁路移植术(CABG)同期(CCAB,643例)与分期(415例)的结局。CCAB组30天心肌梗死加权发生率低于分期组(5.5% vs 11.5%,P<.01),长期心肌梗死风险分期组更高(HR 1.49,95%CI 1.07-2.08,P=.02),而卒中与死亡短期及长期风险相似。作者认为CCAB看似安全,可作为同等合理的选择。
要点
- CCAB组30天心肌梗死加权发生率低于分期组(5.5% vs 11.5%,P<.01)。
- 长期心肌梗死风险分期组高于CCAB组(HR 1.49,95%CI 1.07-2.08,P=.02)。
- 两组30天及长期卒中、死亡风险相似。
核心结论
- 对于因颈动脉狭窄和冠状动脉疾病行CCAB或分期开放血运重建的患者,分期策略术后心脏事件风险增加,但短期和长期卒中与死亡率似乎相当。
- 分期手术间期不良心血管事件风险高,选择策略时应予考虑。
- 尽管导致分期顺序实施的因素需进一步明确,CCAB似乎安全,应被视为同等合理的选择。
研究设计与样本
- 使用血管质量倡议-血管植入物监测与介入结局协调注册网络-Medicare关联数据集,识别2011至2018年行CEA联合CABG或CEA前后45天内行CABG的患者。
- 共纳入1058例患者:CCAB组643例,分期组415例(CEA-CABG 309例,CABG-CEA 106例)。
- 主要结局为最后一次手术后30天内及长期的卒中、心肌梗死、全因死亡、卒中和死亡复合终点以及全部复合终点。
- 采用单变量分析和逆倾向加权风险校正分析,并绘制Kaplan-Meier曲线比较卒中、心肌梗死和死亡。
主要发现
- 与分期组相比,CCAB组术前充血性心力衰竭发生率更高(24.8% vs 18.4%,P=.01),肾功能下降比例更高(14.9% vs 8.5%,P<.01),既往神经系统事件更少(23.5% vs 31.4%,P<.01)。
- CCAB组与分期组30天卒中加权发生率相似(4.6% vs 4.1%,P=.72),死亡相似(7.0% vs 5.0%,P=.32),卒中和死亡复合终点相似(9.8% vs 8.5%,P=.56),卒中、死亡和心肌梗死复合终点相似(14.7% vs 17.4%,P=.31)。
- CCAB组30天心肌梗死加权发生率低于分期组(5.5% vs 11.5%,P<.01)。
- 长期校正后卒中风险(HR 0.85,95%CI 0.54-1.36,P=.51)和死亡率(HR 1.02,95%CI 0.76-1.36,P=.91)两组相似,但分期组长期心肌梗死风险更高(HR 1.49,95%CI 1.07-2.08,P=.02)。
临床怎么用
- 作者认为,对于因颈动脉狭窄和冠状动脉疾病行CCAB或分期开放血运重建的患者,CCAB似乎安全,应被视为同等合理的选择。
- 作者指出,分期手术间期不良心血管事件风险高,选择策略时应予考虑。
- 作者指出,导致分期顺序实施的因素需进一步明确。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Optimal temporal surgical management of significant carotid stenosis and coronary artery disease remains unknown. Carotid endarterectomy (CEA) and coronary artery bypass (CABG) are performed concurrently (CCAB) or in a staged (CEA-CABG or CABG-CEA) approach. Using the Vascular Quality Initiative-Vascular Implant Surveillance and Interventional Outcomes Coordinated Registry Network-Medicare-linked dataset, this study compared operative and long-term outcomes after CCAB and staged approaches. METHODS: The Vascular Quality Initiative-Vascular Implant Surveillance and Interventional Outcomes Coordinated Registry Network dataset was used to identify CEAs from 2011 to 2018 with combined CABG or CABG within 45 days preceding or after CEA. Patients were stratified based on concurrent or staged approach. Primary outcomes were stroke, myocardial infarction (MI), all-cause mortality, stroke and death as composite (SD) and all as composite within 30 days from the last procedure as well as in the long term. Univariate analysis and risk-adjusted analysis using inverse propensity weighting were performed. Kaplan-Meier curves of stroke, MI, and death were created and compared. RESULTS: There were 1058 patients included: 643 CCAB and 415 staged (309 CEA-CABG and 106 CABG-CEA). Compared with staged patients, those undergoing CCAB had a higher preoperative rate of congestive heart failure (24.8% vs 18.4%; P = .01) and decreased renal function (14.9% vs 8.5%; P < .01), as well as fewer prior neurological events (23.5% vs 31.4%; P < .01). Patients undergoing CCAB had similar weighted rate of 30-day stroke (4.6% vs 4.1%; P = .72), death (7.0% vs 5.0%; P = .32), and composite outcomes (stroke and death, 9.8% vs 8.5%; P = .56; stroke, death, and MI, 14.7% vs 17.4%; P = .31), but a lower weighted rate of MI (5.5% vs 11.5%; P < .01) vs the staged cohort. Long-term adjusted risks of stroke (hazard ratio [HR], 0.85; 95% confidence interval [CI], 0.54-1.36; P = .51) and mortality (HR, 1.02; 95% CI, 0.76-1.36; P=.91) were similar between groups, but higher risk of MI long-term was seen in those staged (HR, 1.49; 95% CI, 1.07-2.08; P = .02). CONCLUSIONS: In patients undergoing CCAB or staged open revascularization for carotid stenosis and coronary artery disease, the staged approach had an increased risk of postoperative cardiac event, but the short- and long-term rates of stroke and mortality seem to be comparable. Adverse cardiovascular event risk is high between operations when staged and should be a consideration when selecting an approach. Although factors leading to staged sequencing performance need further clarity, CCAB seems to be safe and should be considered an equally reasonable option.
引用
- Haywood NS, Ratcliffe SJ, Zheng X, et al. Operative and long-term outcomes of combined and staged carotid endarterectomy and coronary bypass. J Vasc Surg. 2023. PMID: 36681256. doi:10.1016/j.jvs.2023.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。